CIPREC - Centro de Investigacion y Prevencion Cardiovascular S.A.

C.a.b.a., Buenos Aires C1119ACN

0 studies enrolling now · 1 studies all time

What they study most

Cardiovascular Disease

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early